Mechanisms and clinical implications of hepatocyte lipoapoptosis

Sophie C. Cazanave, Gregory James Gores

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Nonalcoholic fatty liver disease (NAFLD) is characterized by insulin resistance, elevated serum levels of free fatty acids (FFAs) and fatty infiltration of the liver. Accumulation of triglycerides in the hepatocyte results from the uptake and esterification of circulating FFAs by the liver. Contrary to current theory, hepatic steatosis appears to be a detoxification process, as FFAs are directly cytotoxic for the hepatocyte and inhibition of triglyceride formation enhances FFAs toxicity. Hepatocyte apoptosis is a key feature of NAFLD and correlates with disease severity. Since FFA-induced toxicity, or lipoapoptosis, represents a mechanism for the pathogenesis of NAFLD, this article will highlight the cellular pathways contributing to hepatocyte lipoapoptosis. To date, there is no proven effective therapy for patients with NAFLD and insights into the molecular mediators of lipoapoptosis should help promote effective therapeutic strategies for this disease.

Original languageEnglish (US)
Pages (from-to)71-85
Number of pages15
JournalClinical Lipidology
Volume5
Issue number1
DOIs
StatePublished - 2010

Fingerprint

Nonesterified Fatty Acids
Hepatocytes
Fatty Liver
Triglycerides
Esterification
Insulin Resistance
Apoptosis
Non-alcoholic Fatty Liver Disease
Liver
Therapeutics
Serum

Keywords

  • BH3-only proteins
  • C-Jun N-terminal kinase
  • CCAAT/enhancer binding homologous protein
  • Death receptor
  • Endoplasmic reticulum stress
  • Hepatic steatosis
  • Nonalcoholic steatohepatitis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Mechanisms and clinical implications of hepatocyte lipoapoptosis. / Cazanave, Sophie C.; Gores, Gregory James.

In: Clinical Lipidology, Vol. 5, No. 1, 2010, p. 71-85.

Research output: Contribution to journalArticle

@article{b8ea1284ac77404991b0ea28c3b88963,
title = "Mechanisms and clinical implications of hepatocyte lipoapoptosis",
abstract = "Nonalcoholic fatty liver disease (NAFLD) is characterized by insulin resistance, elevated serum levels of free fatty acids (FFAs) and fatty infiltration of the liver. Accumulation of triglycerides in the hepatocyte results from the uptake and esterification of circulating FFAs by the liver. Contrary to current theory, hepatic steatosis appears to be a detoxification process, as FFAs are directly cytotoxic for the hepatocyte and inhibition of triglyceride formation enhances FFAs toxicity. Hepatocyte apoptosis is a key feature of NAFLD and correlates with disease severity. Since FFA-induced toxicity, or lipoapoptosis, represents a mechanism for the pathogenesis of NAFLD, this article will highlight the cellular pathways contributing to hepatocyte lipoapoptosis. To date, there is no proven effective therapy for patients with NAFLD and insights into the molecular mediators of lipoapoptosis should help promote effective therapeutic strategies for this disease.",
keywords = "BH3-only proteins, C-Jun N-terminal kinase, CCAAT/enhancer binding homologous protein, Death receptor, Endoplasmic reticulum stress, Hepatic steatosis, Nonalcoholic steatohepatitis",
author = "Cazanave, {Sophie C.} and Gores, {Gregory James}",
year = "2010",
doi = "10.2217/clp.09.85",
language = "English (US)",
volume = "5",
pages = "71--85",
journal = "Future Lipidology",
issn = "1746-0875",
publisher = "Future Medicine Ltd.",
number = "1",

}

TY - JOUR

T1 - Mechanisms and clinical implications of hepatocyte lipoapoptosis

AU - Cazanave, Sophie C.

AU - Gores, Gregory James

PY - 2010

Y1 - 2010

N2 - Nonalcoholic fatty liver disease (NAFLD) is characterized by insulin resistance, elevated serum levels of free fatty acids (FFAs) and fatty infiltration of the liver. Accumulation of triglycerides in the hepatocyte results from the uptake and esterification of circulating FFAs by the liver. Contrary to current theory, hepatic steatosis appears to be a detoxification process, as FFAs are directly cytotoxic for the hepatocyte and inhibition of triglyceride formation enhances FFAs toxicity. Hepatocyte apoptosis is a key feature of NAFLD and correlates with disease severity. Since FFA-induced toxicity, or lipoapoptosis, represents a mechanism for the pathogenesis of NAFLD, this article will highlight the cellular pathways contributing to hepatocyte lipoapoptosis. To date, there is no proven effective therapy for patients with NAFLD and insights into the molecular mediators of lipoapoptosis should help promote effective therapeutic strategies for this disease.

AB - Nonalcoholic fatty liver disease (NAFLD) is characterized by insulin resistance, elevated serum levels of free fatty acids (FFAs) and fatty infiltration of the liver. Accumulation of triglycerides in the hepatocyte results from the uptake and esterification of circulating FFAs by the liver. Contrary to current theory, hepatic steatosis appears to be a detoxification process, as FFAs are directly cytotoxic for the hepatocyte and inhibition of triglyceride formation enhances FFAs toxicity. Hepatocyte apoptosis is a key feature of NAFLD and correlates with disease severity. Since FFA-induced toxicity, or lipoapoptosis, represents a mechanism for the pathogenesis of NAFLD, this article will highlight the cellular pathways contributing to hepatocyte lipoapoptosis. To date, there is no proven effective therapy for patients with NAFLD and insights into the molecular mediators of lipoapoptosis should help promote effective therapeutic strategies for this disease.

KW - BH3-only proteins

KW - C-Jun N-terminal kinase

KW - CCAAT/enhancer binding homologous protein

KW - Death receptor

KW - Endoplasmic reticulum stress

KW - Hepatic steatosis

KW - Nonalcoholic steatohepatitis

UR - http://www.scopus.com/inward/record.url?scp=77649132053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649132053&partnerID=8YFLogxK

U2 - 10.2217/clp.09.85

DO - 10.2217/clp.09.85

M3 - Article

AN - SCOPUS:77649132053

VL - 5

SP - 71

EP - 85

JO - Future Lipidology

JF - Future Lipidology

SN - 1746-0875

IS - 1

ER -